Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Mycobacterium tuberculosis | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Mycobacterium leprae | Probable 4-aminobutyrate aminotransferase GabT (GAMMA-AMINO-N-BUTYRATE TRANSAMINASE) (GABA TRANSAMINASE) (GLUTAMATE:SUCCINIC SEM | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | 437 aa | 397 aa | 28.5 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA | 0.0184 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0956 | 1 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0.0276 | 1 |
Mycobacterium tuberculosis | Probable aminotransferase | 0.0184 | 1 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0276 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0956 | 0.36 |
Echinococcus multilocularis | ornithine aminotransferase | 0.0026 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.2166 | 1 |
Echinococcus multilocularis | Aminotransferase class III | 0.0026 | 0 | 0.5 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.0276 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0276 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.2166 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0276 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.2166 | 1 |
Echinococcus granulosus | Aminotransferase class III | 0.0026 | 0 | 0.5 |
Trichomonas vaginalis | acetylornithine aminotransferase, putative | 0.0184 | 1 | 0.5 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.0276 | 1 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.0276 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0956 | 0.4415 |
Brugia malayi | hypothetical protein | 0.003 | 0.0276 | 0.1273 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.2166 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0184 | 1 | 1 |
Echinococcus multilocularis | ornithine aminotransferase | 0.0026 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | acetylornithine transaminase protein | 0.0026 | 0 | 0.5 |
Chlamydia trachomatis | glutamate-1-semialdehyde-2,1-aminomutase | 0.0026 | 0 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0276 | 1 |
Echinococcus granulosus | ornithine aminotransferase | 0.0026 | 0 | 0.5 |
Mycobacterium ulcerans | adenosylmethionine-8-amino-7-oxononanoate aminotransferase | 0.0184 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AC50 (functional) | 2.22 uM | PubChem BioAssay. Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.5012 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.